background
respiratori
virom
integr
part
human
microbiom
character
may
contribut
better
understand
chang
aris
diseas
consequ
influenc
approach
treatment
patient
acut
lower
respiratori
infect
aim
studi
evalu
presenc
respiratori
virus
lower
airway
individu
undergo
invas
mechan
ventil
without
acut
lower
respiratori
infect
respect
wri
wori
group
method
studi
minibronchoalveolar
lavag
sampl
collect
doubl
cathet
kit
patient
mean
age
seventh
decad
wori
group
wri
group
hospit
acut
respiratori
failur
intens
care
unit
two
hospit
lisbon
area
realtim
pcr
appli
verifi
analys
presenc
common
respiratori
virus
adenoviru
human
bocaviru
influenza
viru
b
repiratori
syncyti
viru
human
parainfluenza
viru
type
human
enteroviru
human
rhinoviru
human
metapneumoviru
human
coronaviru
group
result
respiratori
virus
detect
six
patient
wori
group
influenza
n
parainfluenza
viru
n
human
rhinoviru
n
respiratori
syncyti
viru
n
human
metapneumoviru
n
wri
group
respiratori
virus
detect
patient
influenza
n
human
rhinoviru
n
respiratori
syncyti
viru
n
human
metapneumoviru
n
human
bocaviru
n
human
enteroviru
n
simultan
detect
two
virus
record
two
sampl
group
conclus
result
studi
suggest
presenc
common
respiratori
virus
lower
respiratori
tract
without
caus
symptomat
infect
even
care
collect
lower
sampl
may
import
implic
interpret
result
diagnost
set
human
microbiom
firstli
defin
joshua
lederberg
commun
microorgan
live
organ
establish
relationship
commens
symbiosi
pathogen
due
sever
factor
studi
human
virom
neglect
comparison
bacteri
microbiom
name
heterogen
viral
genom
lead
absenc
univers
molecular
marker
ribosom
rna
bacteria
fungal
intern
transcrib
spacer
region
fungi
difficulti
work
small
biomass
sampl
interfer
genet
materi
host
inadequ
bioinformat
instrument
analysi
absenc
robust
databas
particular
case
lung
virom
also
problem
sampl
collect
unlik
mucos
surfac
easili
access
recent
lung
consid
steril
organ
explain
protect
mechan
upper
airway
barrier
function
mucosa
lower
airway
presenc
bacteria
lower
airway
interpret
patholog
phenomenon
base
cultur
microbiolog
inform
explain
transient
migrat
microaspir
reflect
composit
upper
respiratori
tract
although
biomass
would
lower
conced
lower
respiratori
tract
microbiom
could
relat
contamin
upper
tract
sampl
accord
dickson
huffnagl
notion
lung
steril
still
frequent
state
textbook
virtual
alway
without
citat
respiratori
culturebas
protocol
sought
identifi
clinic
signific
pathogen
begin
current
decad
studi
base
cultureindepend
method
shown
presenc
small
amount
bacteri
commun
lung
healthi
nonsmok
individu
divers
element
studi
avail
literatur
character
respiratori
tract
virom
especi
lower
airway
essentiali
studi
popul
pediatr
age
major
respiratori
infect
observ
made
studi
base
upper
respiratori
tract
sampl
like
nasopharyng
swab
nasal
mucosa
exud
greater
access
assum
result
obtain
could
translat
happen
lower
airway
object
studi
evalu
presenc
respiratori
virus
lower
airway
individu
without
acut
lower
respiratori
infect
undergo
invas
mechan
ventil
order
achiev
evalu
presenc
common
respiratori
virus
popul
lower
airway
sampl
collect
individu
without
respiratori
infect
undergo
mechan
ventil
use
realtim
polymeras
chain
reaction
revers
transcriptionpolymeras
chain
reaction
respect
pcr
rtpcr
techniqu
prospect
observ
studi
analyz
minibronchoalveolar
lavag
minib
sampl
invas
mechan
ventil
patient
two
polival
intens
care
unit
icu
lisbon
district
portug
patient
divid
two
group
wori
group
includ
patient
admit
caus
respiratori
infect
receiv
antibiot
therapi
respiratori
symptom
exclud
time
admiss
name
cough
sputum
chest
xray
perform
patient
exclud
lower
respiratori
infect
possibl
obtain
reliabl
inform
presenc
respiratori
symptom
admiss
influenza
vaccin
histori
wri
group
includ
patient
admit
acut
respiratori
infect
antibiot
therapi
patient
enrol
studi
requir
endotrach
intub
treat
acut
respiratori
failur
exclus
criteria
age
less
year
pregnanc
immunosupress
antivir
therapi
admiss
particip
legal
repres
inform
studi
object
sign
consent
obtain
previous
sampl
collect
ethic
committe
particip
center
approv
studi
protocol
patient
demograph
comorbid
acut
physiolog
chronic
health
evalu
apach
ii
score
simplifi
acut
physiolog
score
sap
ii
admiss
diagnosi
icu
clinic
outcom
record
sampl
collect
perform
kit
decemb
march
protect
minib
doubl
cathet
kit
plastim
saintleula
franc
perform
first
h
tracheal
intub
invas
mechan
ventil
combicath
introduc
blindli
orotrach
tubeuntil
end
lower
third
trachea
wedg
bronchial
tree
minib
sampl
obtain
intil
ml
room
temperatur
salin
solut
follow
gentl
suction
infus
aliquot
sampl
store
process
clinic
sampl
process
use
qiamp
minelut
viru
spin
kit
extract
accord
manufactur
instruct
qiagen
valencia
ca
hous
realtim
taqman
pcr
rtpcr
techniqu
detail
elsewher
use
detect
dna
rna
respiratori
virus
adenoviru
human
bocaviru
hbov
influenza
viru
ab
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
hpiv
type
human
enteroviru
hev
human
rhinoviru
hrv
human
metapneumoviru
hmpv
human
coronaviru
hcov
group
descript
analysi
perform
valu
express
percentag
discret
variabl
mean
continu
variabl
total
patient
includ
studi
wori
group
wri
group
baselin
patient
characterist
admiss
diagnos
summar
tabl
median
age
year
year
patient
male
apach
ii
sap
ii
medium
score
respect
medium
icu
length
stay
day
day
total
patient
die
icu
virus
detect
depict
tabl
wori
group
patient
posit
wri
group
patient
posit
cycl
threshold
ct
vari
wori
group
wri
group
wori
group
follow
virus
identifi
influenza
hpiv
rsv
hmpv
hrv
two
sampl
two
virus
detect
simultan
influenza
hrv
one
sampl
hmpv
hrv
one
patient
die
icu
influenza
virus
hpiv
hrv
present
one
sampl
wri
group
detect
influenza
rsv
hmpv
hrv
hev
hbov
influenza
viru
rsv
hmpv
hrv
identifi
three
sampl
hbov
identifi
two
sampl
hev
one
sampl
three
case
associ
two
virus
hev
hrv
influenza
hmpv
hmpv
hbov
six
case
bacteri
coinfect
staphylococcu
aureu
n
moraxella
catarrhali
n
streptococcu
pneumonia
n
detect
routin
microbiolog
procedur
case
lower
respiratori
infect
none
nine
patient
viral
bacteri
viral
coinfect
die
icu
wori
group
patient
posit
sampl
wori
older
patient
neg
sampl
wori
vs
year
also
wori
patient
higher
mean
sever
score
apach
ii
vs
sap
ii
vs
lower
icu
length
stay
vs
day
invas
mechan
ventil
day
vs
higher
mortal
rate
vs
tabl
concern
wri
group
mean
age
year
subgroup
patient
wri
studi
possibl
identifi
common
respiratori
virus
sampl
lower
respiratori
tract
adult
invas
mechan
ventil
regardless
presenc
absenc
acut
lower
respiratori
infect
realtim
pcr
techniqu
field
pulmonari
virolog
investig
sever
factor
make
studi
innov
age
type
patient
inclus
two
group
patient
wri
group
without
acut
lower
respiratori
infect
wori
group
also
type
sampl
protect
sampl
distal
lower
respiratori
tract
accord
luyt
et
al
bal
respiratori
sampl
choic
evalu
lung
infect
nucleic
acid
extract
perform
commerci
kit
use
studi
wang
et
al
anal
respiratori
virom
healthi
sever
acut
respiratori
infect
children
metagenom
analysi
use
inhous
realtim
pcr
rtpcr
techniqu
test
valid
long
thirti
percent
patient
belong
wori
group
common
respiratori
virus
distal
lower
respiratori
tract
accord
data
pediatr
popul
lung
virom
asymptomat
individu
less
divers
infect
individu
consist
mostli
member
anellovirida
famili
lower
percentag
common
epidem
respiratori
virus
studi
wang
et
al
sampl
infect
patient
six
sevenfold
viral
pathogen
wri
group
author
suggest
viral
infect
may
asymptomat
occasion
prolong
make
controversi
interpret
posit
pcr
virus
studi
conduct
choi
et
al
main
respiratori
virus
associ
sever
pneumonia
adult
admit
icu
hrv
hpiv
hmpv
influenza
rsv
accord
data
obtain
realtim
pcr
analysi
bronchoalveolar
lavag
sampl
studi
xu
et
al
sampl
collect
nasopharyng
swab
infect
children
analyz
realtim
pcr
use
panel
respiratori
virus
percentag
posit
sampl
studi
half
wri
group
patient
posit
sampl
compar
two
group
influenza
preval
viru
coincid
peak
influenza
portug
rsv
hmpv
hrv
common
group
differ
found
hpiv
preval
uninfect
patient
hev
hbov
found
wri
group
analysi
ct
valu
show
similar
viral
load
group
although
slightli
tendenc
lower
ct
valu
wori
group
small
number
sampl
allow
us
draw
conclus
possibl
differ
viral
load
infect
uninfect
individu
may
hypothes
respiratori
virus
influenza
rsv
hmpv
hrv
may
transient
colon
mucosa
tracheobronchi
tract
time
increas
viral
activ
wherea
other
hpiv
might
prolong
colon
howev
longitudin
studi
could
determin
extent
colon
period
thu
solv
import
issu
addit
need
know
mean
presenc
bystand
even
acut
respiratori
infect
respons
symptomat
infect
lower
respiratori
tract
studi
limit
includ
small
sampl
size
limit
number
center
involv
allow
us
make
infer
mortal
group
subgroup
addit
patient
group
sever
ill
therefor
observ
made
studi
may
generaliz
group
particular
healthi
popul
although
sign
symptom
respiratori
infect
exclud
admiss
wori
group
viral
respiratori
infect
last
week
preced
hospit
exclud
therefor
viral
detect
case
could
result
recent
infect
extend
stay
lower
respiratori
tract
studi
protect
minib
doubl
cathet
kit
use
order
reduc
upper
level
contamin
howev
possibl
contamin
upper
respiratori
secret
mainli
due
ventil
process
may
import
contribut
detect
rate
observ
studi
anoth
limit
relat
methodolog
use
although
realtim
pcr
current
goldstandard
diagnosi
viral
infect
methodolog
limit
specif
target
sequenc
fact
common
respiratori
virus
investig
accord
willner
et
al
pcrbase
studi
confer
incomplet
airway
virom
pictur
littl
opportun
discoveri
new
agent
compar
metagenom
techniqu
independ
genom
sequenc
addit
virus
like
herpesviru
simplex
cytomegaloviru
torqu
teno
viru
present
distal
airway
mucosa
therefor
may
miss
pcr
strategi
howev
despit
limit
main
respiratori
virus
properli
search
group
major
concern
deal
respiratori
infect
anoth
import
advantag
studi
focu
popul
undergo
invas
mechan
ventil
allow
collect
sampl
distal
airway
although
blindli
usual
limit
type
studi
result
studi
suggest
presenc
common
respiratori
virus
lower
respiratori
tract
without
determin
symptomat
infect
even
care
collect
lower
sampl
may
import
implic
interpret
result
diagnost
set
accomplish
longitudin
studi
would
allow
elucid
length
stay
virus
respiratori
tract
exist
perman
viral
commun
environ
applic
applic
dataset
use
andor
analys
current
studi
avail
correspond
author
request
author
contribut
rn
studi
design
data
collect
acquisit
analysi
interpret
data
manuscript
write
edit
mjc
studi
design
analysi
interpret
data
manuscript
write
edit
mlr
analysi
interpret
data
manuscript
write
edit
cp
cc
us
data
collect
acquisit
analysi
data
data
collect
acquisit
analysi
interpret
data
ms
analysi
interpret
data
prp
pcp
concept
studi
design
analysi
interpret
data
manuscript
write
edit
author
read
approv
final
manuscript
work
fund
infect
unit
nova
medic
school
academ
unit
nova
univers
lisbon
studi
approv
ethic
committe
beatriz
angelo
hospit
nref
ethic
committe
francisco
xavier
hospit
ce
decemb
patient
legal
repres
gave
written
inform
consent
particip
studi
author
member
infect
unit
faculti
medic
sciencesnova
medic
school
particip
studi
design
collect
analysi
sampl
interpret
data
write
manuscript
